Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $4.04 in the prior trading day, Artiva Biotherapeutics Inc (NASDAQ: ARTV) closed at $4.27, up 5.69%. In other words, the price has increased by $5.69 from its previous closing price. On the day, 0.66 million shares were traded. ARTV stock price reached its highest trading level at $4.75 during the session, while it also had its lowest trading level at $3.64.
Ratios:
Our goal is to gain a better understanding of ARTV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.33 and its Current Ratio is at 11.33. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $20.
On August 13, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 22 ’24 when RA CAPITAL MANAGEMENT, L.P. bought 8,333,333 shares for $12.00 per share. The transaction valued at 99,999,996 led to the insider holds 8,693,579 shares of the business.
5AM Partners VI, LLC bought 833,333 shares of ARTV for $9,999,996 on Jul 22 ’24. The 10% Owner now owns 1,182,054 shares after completing the transaction at $12.00 per share. On Jul 22 ’24, another insider, venBio Global Strategic Fund I, who serves as the 10% Owner of the company, bought 416,666 shares for $12.00 each. As a result, the insider paid 4,999,992 and bolstered with 1,936,637 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARTV now has a Market Capitalization of 103715312 and an Enterprise Value of -27947570. Its current Enterprise Value per Revenue stands at -10.745 whereas that against EBITDA is 0.477.
Stock Price History:
Over the past 52 weeks, ARTV has reached a high of $17.31, while it has fallen to a 52-week low of $3.37. The 50-Day Moving Average of the stock is -18.16%, while the 200-Day Moving Average is calculated to be -56.59%.
Shares Statistics:
The stock has traded on average 83.46K shares per day over the past 3-months and 173210 shares per day over the last 10 days, according to various share statistics. A total of 24.29M shares are outstanding, with a floating share count of 11.95M. Insiders hold about 50.78% of the company’s shares, while institutions hold 63.35% stake in the company. Shares short for ARTV as of 1740700800 were 1124353 with a Short Ratio of 13.47, compared to 1738281600 on 1167703. Therefore, it implies a Short% of Shares Outstanding of 1124353 and a Short% of Float of 4.66.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
